Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


In this issue


Illustration of breast cancer and hormone replacement therapy (HRT)

Assessing the safety of hormonal replacement therapySubscription

By ,

Since the dawn of hormonal replacement therapy — now known as menopausal hormone therapy — there have been conflicting reports about its risks and safety. A thorough examination of the evidence suggests it can be used safely in menopausal women.

CPD article

Testing for blood clotting

How to identify causes of a subtherapeutic INRSubscription

By ,

Pharmacists and healthcare professionals are often involved in the management of patients with subtherapeutic international normalised ratios (INRs), the cause of which is important to identify because this will affect decisions and the subsequent management of the patient.


Coloured X-ray angiogram of a balloon catheter and stent (brown, upper centre) being placed within a coronary artery of a heart

Role of coronary drug-eluting stents in current clinical practiceSubscription

By , ,

Percutaneous coronary intervention (PCI) has continued to evolve, from its origins in balloon angioplasty and bare metal stent (BMS) implantation, to the development and application of contemporary drug-eluting stents (DESs). While first generation DESs significantly decreased risk of in-stent restenosis observed with BMSs, their use was complicated by late and very late stent thrombosis. Second generation DESs have dramatically decreased this risk and the rate of one-year stent thrombosis ...

Short communications

Article on statin safety makes unproven assertionsSubscription


With publication of the review article in The Lancet on 8 September 2016 looking at the efficacy and safety of statin therapy, the pressure on GPs to prescribe high-intensity statins to low-risk people has become even greater. Under the heading ‘Proven beneficial effects of statin therapy’, the review states: “Lowering low-density lipoprotein (LDL) cholesterol by 2mmol/L with an effective statin regimen for about five years in 10,000 patients would typically prevent major vascular ...

Incorporating immunisation training into the undergraduate pharmacy courseSubscription


Vaccines save 2.5 million lives each year globally. Not only do they decrease the global burden of preventative diseases, they also altruistically spread herd immunity to the community and drive down the costs of healthcare. Since the 20th century, pharmacists have contributed to this public health initiative through their roles as educators, distributers, dispensers, and advocators. And while a pharmacist’s immunisation roles vary depending on the country, the International Pharmaceutical ...

Impact of a pharmacist-led asthma and COPD respiratory clinic in general practiceSubscription

By , ,

Asthma and chronic obstructive pulmonary disease (COPD) continue to account for a large burden of disease in the UK. Despite comprehensive guidelines, more than 1,000 people die from asthma each year and COPD accounts for a leading cause of emergency admissions in the UK. In a joint initiative between NHS City and Hackney clinical commissioning group and the local tertiary centre for respiratory disease Barts Health NHS Trust, asthma and COPD reviews were undertaken by a specialist ...

Clinical Pharmacist

CP November 2016, Vol 8, No 11

Cover Story:

Evolution of drug-eluting stent technologies

Read more…

Clinical Pharmacist

View previous issue

Clinical Pharmacist is a monthly, peer-reviewed journal that provides authoritative resources on the clinical management of disease in relation to medicines and up-to-date information about advances in pharmacy and drug development. Clinical Pharmacist publishes Review articles, Perspectives, evidence-based CPD articles and Research articles on topics from drug discovery to clinical pharmacology and pharmacy.

The international audience of Pharmaceutical Journal Publications consists of pharmacists, pharmaceutical scientists and healthcare professionals. The journal is available to 44,000 members of the Royal Pharmaceutical Society, as well as non-member individual subscribers and subscribing institutions.